Meyers K - Search Results

1

Lessons for Patient Education Around Long-Acting Injectable PrEP: Findings from a Mixed-Method Study of Phase II Trial Participants.

Meyers K, Rodriguez K, Brill AL, Wu Y, La Mar M, Dunbar D, Koblin B, Margolis D, Sobieszczyk ME, Van Tieu H, Frank I, Markowitz M, Golub SA. Meyers K, et al. AIDS Behav. 2018 Apr;22(4):1209-1216. doi: 10.1007/s10461-017-1871-x. AIDS Behav. 2018. PMID: 28744666 Free PMC article. Clinical Trial.

2

High interest in a long-acting injectable formulation of pre-exposure prophylaxis for HIV in young men who have sex with men in NYC: a P18 cohort substudy.

Meyers K, Rodriguez K, Moeller RW, Gratch I, Markowitz M, Halkitis PN. Meyers K, et al. PLoS One. 2014 Dec 11;9(12):e114700. doi: 10.1371/journal.pone.0114700. eCollection 2014. PLoS One. 2014. PMID: 25502768 Free PMC article.

3

Extending access with long-acting antiretroviral therapy: the next advance in HIV-1 therapeutics and prevention.

Markowitz M, Meyers K. Markowitz M, et al. Among authors: meyers k. Curr Opin HIV AIDS. 2015 Jul;10(4):216-8. doi: 10.1097/COH.0000000000000167. Curr Opin HIV AIDS. 2015. PMID: 26049944 No abstract available.

4

Planning ahead for implementation of long-acting HIV prevention: challenges and opportunities.

Meyers K, Golub SA. Meyers K, et al. Curr Opin HIV AIDS. 2015 Jul;10(4):290-5. doi: 10.1097/COH.0000000000000159. Curr Opin HIV AIDS. 2015. PMID: 26049956 Free PMC article. Review.

5

Interest in Long-Acting Injectable PrEP in a Cohort of Men Who have Sex with Men in China.

Meyers K, Wu Y, Qian H, Sandfort T, Huang X, Xu J, Zhang J, Xia W, Glidden D, Wu H, Shang H. Meyers K, et al. AIDS Behav. 2018 Apr;22(4):1217-1227. doi: 10.1007/s10461-017-1845-z. AIDS Behav. 2018. PMID: 28707025 Free PMC article.

6

Modelling the Epidemiological Impact and Cost-Effectiveness of PrEP for HIV Transmission in MSM in China.

Zhang L, Peng P, Wu Y, Ma X, Soe NN, Huang X, Wu H, Markowitz M, Meyers K. Zhang L, et al. Among authors: meyers k. AIDS Behav. 2019 Feb;23(2):523-533. doi: 10.1007/s10461-018-2205-3. AIDS Behav. 2019. PMID: 29971734 Free PMC article.

7

To switch or not to switch: Intentions to switch to injectable PrEP among gay and bisexual men with at least twelve months oral PrEP experience.

Meyers K, Wu Y, Brill A, Sandfort T, Golub SA. Meyers K, et al. PLoS One. 2018 Jul 19;13(7):e0200296. doi: 10.1371/journal.pone.0200296. eCollection 2018. PLoS One. 2018. PMID: 30024903 Free PMC article.

8

Mapping Potential Pre-Exposure Prophylaxis Users onto a Motivational Cascade: Identifying Targets to Prepare for Implementation in China.

Wu Y, Xie L, Meng S, Hou J, Fu R, Zheng H, He N, Meyers K. Wu Y, et al. Among authors: meyers k. LGBT Health. 2019 Jul;6(5):250-260. doi: 10.1089/lgbt.2018.0256. Epub 2019 Jun 6. LGBT Health. 2019. PMID: 31170020 Free PMC article.

9

Risk Behavior Not Associated with Self-Perception of PrEP Candidacy: Implications for Designing PrEP Services.

Xie L, Wu Y, Meng S, Hou J, Fu R, Zheng H, He N, Wang M, Meyers K. Xie L, et al. Among authors: meyers k. AIDS Behav. 2019 Oct;23(10):2784-2794. doi: 10.1007/s10461-019-02587-5. AIDS Behav. 2019. PMID: 31280397 Free PMC article.

10

Behavioral and social science research to support accelerated and equitable implementation of long-acting preexposure prophylaxis.

Meyers K, Price D, Golub S. Meyers K, et al. Curr Opin HIV AIDS. 2020 Jan;15(1):66-72. doi: 10.1097/COH.0000000000000596. Curr Opin HIV AIDS. 2020. PMID: 31644482 Free PMC article. Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

627 results

Search Page

Filters